Search Within

Juan Carlos Osorio

Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
  3. Editorial (1)
Groups
  1. GDMT, Medicine (15)
  2. GME, Medicine (15)
  3. Graduate Medical Education (15)
  4. Gynecology Disease Management Team (15)
  5. Hematology-Oncology Fellows (15)
  6. Department of Medicine (12)

More Groups

People
  1. Matthew Hellmann (6)
  2. Andrew Plodkowski (4)
  3. Hira Rizvi (4)
  4. Mark Kris (3)
  5. Michelle Ginsberg (3)
  6. Carlo miguel Sevilla (2)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (1)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Immunology Research (2)
  3. Annals of Oncology (1)
  4. Cancer Cell (1)
  5. Cancer Research (1)
  6. International Journal of Radiation Oncology, Biology, Physics (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. American Association for Cancer Research (3)
  3. Cell Press (2)
  4. Elsevier Inc. (2)
  5. Ame Publ Co (1)
  6. American Society for Clinical Investigation (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
    Meeting Abstract

    Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Protocol for assessing antibody-dependent cellular phagocytosis by primary murine and human macrophages
    Journal Article

    Sevilla, C. M.; Mijacika, A.; Somoza, B.; Osorio, J. C.
    STAR Protocols (2025)

    Fulltext@MSK | Save
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Endometrial carcinoma in Black vs Asian women: Racial disparities and opportunities to improve survival in 219,301 patients in the USA
    Meeting Abstract

    Becerra, H. A.; Ilerhunmwuwa, N. P.; Wasifuddin, M.; Uche, I.; Osorio, J. C.; Wang, J. C. C.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer
    Journal Article

    Gómez-Banoy, N.; Ortiz, E.; Jiang, C. S.; Dagher, C.; Sevilla, C.; Girshman, J.; Pagano, A.; Plodkowski, A.; Zammarrelli, W. A.; Mueller, J. J.; more...
    Journal of Clinical Investigation (2024)

    Fulltext@MSK | Save
  • FcgRIIB is an immune checkpoint limiting the activity of Treg-targeting antibodies in the tumor microenvironment
    Journal Article

    Knorr, D. A.; Blanchard, L.; Leidner, R. S.; Jensen, S. M.; Meng, R.; Jones, A.; Ballesteros-Merino, C.; Bell, R. B.; Baez, M.; Marino, A.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions
    Journal Article

    Osorio, J. C.; Smith, P.; Knorr, D. A.; Ravetch, J. V.
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Deciphering radiological stable disease to immune checkpoint inhibitors
    Journal Article

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Callahan, M. K.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Beyond T cells: IgA incites immune recognition in endometrial cancer
    Editorial

    Osorio, J. C.; Zamarin, D.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Determination of clinical benefit among patients with radiological stable disease to immune checkpoint inhibitors
    Meeting Abstract

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Gupta, A. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save